What is HealthEquity's price / sales?

HealthEquity (HQY) reported price / sales of 5.2× in Q1 2026.

How has HealthEquity's price / sales changed year-over-year?

HealthEquity's price / sales decreased by 13.2% year-over-year, from 6× to 5.2×.

What is the long-term trend for HealthEquity's price / sales?

Over 5 years (2021 to 2026), HealthEquity's price / sales has grown at a -10.2% compound annual growth rate (CAGR), from 9.5× to 5.6×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

HealthEquity HQY Price / sales

Price / sales at other companies

UnitedHealth GroupUNH

0.5×-0.6×

Webster Financial CorporationWBS

3.8×+0.5×

Willis Towers WatsonWTW

2.8×-0.7×

CVS HealthCVS

0.2×0.0×

CenteneCNC

0.1×-0.1×

Voya FinancialVOYA

——

Other financials

Income statement

See full

Revenue$354.6M+7.2%

Gross profit$256.3M+14.3%

Operating income$103.0M+23.9%

Net income$69.4M+28.8%

EPS (diluted)$0.82+34.4%

Balance sheet

See full

Cash & equivalents$265.4M-7.8%

Total debt$984.7M-11.0%

Total equity$2.0B-3.6%

Total assets$3.3B-3.2%

Cash flow

See full

Operating cash flow$97.5M+50.6%

CapEx$362.0K+321%

Free cash flow$97.2M+50.3%

Valuation

See full

Market cap$7.12B-6.7%

Enterprise value$7.84B-7.2%

P/E30.9×-31.8×

Profitability

See full

Gross margin70.7%+5.2pp

Operating margin25.6%+9.2pp

Net margin17.3%+7.5pp

FCF margin36.5%+9.3pp

Returns & leverage

See full

Return on equity11.1%+5.3pp

Debt / equity0.5×0.0×

Current ratio3.4×-0.6×

Where this comes from

Calculated from HealthEquity’s reported figures.

market cap/total revenue=5.2×

Based on the most recent quarter.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HealthEquity's price / sales?: HealthEquity (HQY) reported price / sales of 5.2× in Q1 2026.
How has HealthEquity's price / sales changed year-over-year?: HealthEquity's price / sales decreased by 13.2% year-over-year, from 6× to 5.2×.
What is the long-term trend for HealthEquity's price / sales?: Over 5 years (2021 to 2026), HealthEquity's price / sales has grown at a -10.2% compound annual growth rate (CAGR), from 9.5× to 5.6×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.